Ablation of AMP-activated Protein Kinase α2 Activity Exacerbates Insulin Resistance Induced by High-fat Feeding of Mice

  1. Nobuharu Fujii, PhD1,
  2. Richard C. Ho, PhD1,
  3. Yasuko Manabe, PhD1,
  4. Niels Jessen, M.D1,
  5. Taro Toyoda, PhD1,
  6. William L. Holland, PhD2,
  7. Scott A. Summers, PhD2,
  8. Michael F. Hirshman, B.S1 and
  9. Laurie J. Goodyear, PhD (laurie.goodyear{at}joslin.harvard.edu)1
  1. 1Research Division, Joslin Diabetes Center and Department Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
  2. 2Division of Endocrinology, Diabetes, and Metabolism, University of Utah School of Medicine, Salt Lake City, UT

    Abstract

    Objective: We determined if muscle AMP-activated protein kinase (AMPK) has a role in the development of insulin resistance.

    Research Design And Methods: Muscle-specific transgenic mice expressing an inactive form of the AMPK α2 catalytic subunit (α2i TG) and their wild type littermates were fed either a high-fat (60% kcal fat) or a control diet (10% kcal fat) for 30 weeks.

    Results: Compared with wild type mice, glucose tolerance in α2i TG mice was slightly impaired on the control diet, and significantly impaired on the high-fat diet. To determine whether the whole body glucose intolerance was associated with impaired insulin sensitivity in skeletal muscle, glucose transport in response to submaximal insulin (450 μU/ml) was measured in isolated soleus muscles. On the control diet, insulin-stimulated glucose transport was reduced by approximately 50% in α2i TG mice compared with wild type mice. High fat feeding partially decreased insulin-stimulated glucose transport in wild type mice, while the high fat feeding resulted in a full blunting of insulin-stimulated glucose transport in the α2iTG mice. High fat feeding in α2i TG mice was accompanied by decreased expression of insulin signaling proteins in gastrocnemius muscle.

    Conclusions: The lack of skeletal muscle AMPK α2 activity exacerbates the development of glucose intolerance and insulin resistance caused by high-fat feeding, and supports the thesis that AMPK α2 is an important target for the prevention/amelioration of skeletal muscle insulin resistance through lifestyle (exercise) and pharmacologic (e.g. metformin) treatments.

    Footnotes

      • Received August 23, 2007.
      • Accepted August 16, 2008.